Wow! The minions of the shorts are now begging at the swamp. They must know it is almost over for them at least using their present aliases. I wonder how many will end up making it on our John Does list. EROS had 31 if I remember correctly but when you eliminate the multi aliases I would bet there are less than a dozen. It sure would be great if things work out so we can begin 2018 on the NASDAQ. With our pipeline I am sure we would attract lots of institutional investors making our shares even more precious than they are today. Go IPIX!!!
(6)
(1)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links